With companies paying substantial sums for marketing rights over deuterated drugs, Michael Furrow and Erin Austin examine critical patent strategies and considerations.
Related Services
Related Insights
INTA Successfully Advocates to Increase TTAB Precedent and Leads to Change
INTA Successfully Advocates to Increase TTAB Precedent and Leads to Change
September 22, 2021
1min
New Dance Moves? Purple Book Amendments Require Public Disclosure of ‘Patent Dance’ Patent Lists
New Dance Moves? Purple Book Amendments Require Public Disclosure of ‘Patent Dance’ Patent Lists
July 12, 2021
1min
Supreme Court Upholds and Limits Assignor Estoppel in Patent Cases
Supreme Court Upholds and Limits Assignor Estoppel in Patent Cases
June 29, 2021
4min
Events
Creating Pathways to Diversity® Conference
Creating Pathways to Diversity® Conference
October 11, 2021 Minority Corporate Counsel Association
Recent News
Am Law Global 200 Recognizes Venable Among the World’s Highest-Grossing Law Firms
Am Law Global 200 Recognizes Venable Among the World’s Highest-Grossing Law Firms
September 22, 2021
1min
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
September 22, 2021
2min
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
September 21, 2021
2min